AUPH

Aurinia Pharmaceuticals Inc

5.77 USD
-0.01 (-0.17%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Aurinia Pharmaceuticals Inc stock is down -25.36% since 30 days ago. The next earnings date is May 2, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 54.55% of the previous 10 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
15 Feb 19:34 19 Jul, 2024 8.00 CALL 862 188
16 Feb 14:55 17 Jan, 2025 15.00 PUT 40 159
20 Feb 19:27 19 Apr, 2024 5.00 PUT 9998 725
21 Feb 20:30 19 Jul, 2024 7.00 CALL 775 310
21 Feb 20:50 17 Jan, 2025 10.00 CALL 910 3988
22 Feb 15:45 19 Jul, 2024 6.00 CALL 500 288
22 Feb 15:52 19 Apr, 2024 6.00 CALL 1000 1776
22 Feb 17:04 15 Mar, 2024 7.00 PUT 200 1341
22 Feb 18:43 15 Mar, 2024 6.00 CALL 962 1178
23 Feb 20:53 19 Jul, 2024 7.00 CALL 775 1092

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc. focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis.

  • Cantor Fitzgerald
    Fri Feb 23, 12:09
    buy
    confirm
  • HC Wainwright & Co.
    Thu Feb 22, 06:42
    buy
    confirm
  • RBC Capital
    Fri Feb 16, 11:11
    buy
    confirm